Literature DB >> 12762588

Analysis of the linkage of the Taq1A and Taq1B loci of the dopamine D2 receptor gene with schizophrenia in patients and their siblings.

V E Golimbet1, M G Aksenova, V V Nosikov, V A Orlova, V G Kaleda.   

Abstract

The linkage of the polymorphous markers Taq1A and Taq1B of the DRD2 dopamine receptor gene, located in region 11q22-11q23 of chromosome 11, with schizophrenia was studied. The investigation involved 29 complete families containing concordant and discordant sibling pairs. Common alleles at locus Taq1A were found significantly more frequently in concordant pairs (p = 0.04), and there was a tendency to a higher frequency of transmission of the maternal allele as compared with the paternal allele (p = 0.06). No such relationships were seen in the case of the Taq1B locus. Neither locus showed any significant difference in the frequency of common alleles in discordant pairs or in the predominance of allele transmission from one of the parents. These data demonstrate a possible linkage with schizophrenia for the Taq1A marker but not for the Taq1B marker.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12762588     DOI： 10.1023/a:1022191012698

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN： 0097-0549


  10 in total

1.  Chromosome Workshop: chromosomes 11, 14, and 15.

Authors:  N Craddock; C Lendon
Journal:  Am J Med Genet       Date:  1999-06-18

2.  Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism.

Authors:  E P Noble; K Blum; T Ritchie; A Montgomery; P J Sheridan
Journal:  Arch Gen Psychiatry       Date:  1991-07

3.  [Association of allele polymorphism of dopamine d2 receptors with schizophrenic and affective disorders].

Authors:  V E Golimbet; M G Aksenova; L I Abramova; V G Kaleda; V A Orlova; E A Braga; V V Nosikov; V I Trubnikov
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  1998

Review 4.  A functionally deficient DRD2 variant [Ser311Cys] is not linked to alcoholism and substance abuse.

Authors:  D Goldman; M Urbanek; D Guenther; R Robin; J C Long
Journal:  Alcohol       Date:  1998-07       Impact factor: 2.405

5.  Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia.

Authors:  T Tanaka; S Igarashi; O Onodera; H Tanaka; N Fukushima; M Takahashi; K Kameda; S Tsuji; S Ihda
Journal:  Am J Med Genet       Date:  1996-04-09

6.  Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders.

Authors:  H Manki; S Kanba; T Muramatsu; S Higuchi; E Suzuki; S Matsushita; Y Ono; H Chiba; F Shintani; M Nakamura; G Yagi; M Asai
Journal:  J Affect Disord       Date:  1996-09-09       Impact factor: 4.839

7.  Asymptotic properties of affected-sib-pair linkage analysis.

Authors:  P Holmans
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

8.  PCR detection of the TaqA RFLP at the DRD2 locus.

Authors:  D K Grandy; Y Zhang; O Civelli
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

9.  D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.

Authors:  J Thompson; N Thomas; A Singleton; M Piggott; S Lloyd; E K Perry; C M Morris; R H Perry; I N Ferrier; J A Court
Journal:  Pharmacogenetics       Date:  1997-12

10.  Two-locus maximum lod score analysis of a multifactorial trait: joint consideration of IDDM2 and IDDM4 with IDDM1 in type 1 diabetes.

Authors:  H J Cordell; J A Todd; S T Bennett; Y Kawaguchi; M Farrall
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025
  10 in total
  8 in total

1.  Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Rajendra D Badgaiyan; Tomas Palomo; Mark S Gold
Journal:  Med Hypotheses       Date:  2014-02-26       Impact factor: 1.538

2.  Pharmacogenetics of Addiction Therapy.

Authors:  David P Graham; Mark J Harding; David A Nielsen
Journal:  Methods Mol Biol       Date:  2022

3.  A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study.

Authors:  C J Spellicy; M J Harding; S C Hamon; J J Mahoney; J A Reyes; T R Kosten; T F Newton; R De La Garza; D A Nielsen
Journal:  Genes Brain Behav       Date:  2014-03-17       Impact factor: 3.449

Review 4.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

5.  Genetic susceptibility in solvent induced neurobehavioral effects.

Authors:  L Godderis; N Maertens; V de Gelder; A De Lamper; K De Ruyck; M Vernimmen; S Bulterys; G Moens; H Thierens; M K Viaene
Journal:  Neurotox Res       Date:  2009-08-22       Impact factor: 3.911

6.  ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.

Authors:  Catherine J Spellicy; Thomas R Kosten; Sara C Hamon; Mark J Harding; David A Nielsen
Journal:  Pharmacogenet Genomics       Date:  2013-07       Impact factor: 2.089

7.  The ANKK1 kinase gene and psychiatric disorders.

Authors:  Guillermo Ponce; Rocío Pérez-González; María Aragüés; Tomás Palomo; Roberto Rodríguez-Jiménez; Miguel Angel Jiménez-Arriero; Janet Hoenicka
Journal:  Neurotox Res       Date:  2009-04-07       Impact factor: 3.911

Review 8.  Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation.

Authors:  Md Mominur Rahman; Md Rezaul Islam; Sadia Afsana Mim; Nasrin Sultana; Dinesh Kumar Chellappan; Kamal Dua; Mohammad Amjad Kamal; Rohit Sharma; Talha Bin Emran
Journal:  Oxid Med Cell Longev       Date:  2022-09-21       Impact factor: 7.310
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.